West Tower Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-74
Closed -$34.9K 219
2023
Q4
$34.9K Buy
+74
New +$34.2K 0.07% 225
2023
Q3
Sell
-123
Closed -$54.6K 666
2023
Q2
$54.6K Buy
+123
New +$56.7K 0.04% 195

Other funds holding ELV

West Tower Group's ELV Position: Q1 2024 in Review

West Tower Group sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 74 shares — an estimated $34.9K sold.

West Tower Group first reported a position in ELV in Q2 2023 and held it in 2 quarters. The position peaked at $54.6K in Q2 2023. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • West Tower Group reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 74 Elevance Health shares in Q1 2024, an estimated $34.9K.
  • West Tower Group first reported a position in Elevance Health in Q2 2023 and held it in 2 quarters.
  • West Tower Group's Elevance Health position peaked at $54.6K in Q2 2023.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.